精准医疗时代的乳腺癌前哨淋巴结活检

doi:10.6040/j.issn.1671-7554.0.2022.0612

摘要/Abstract

摘要： 乳腺癌前哨淋巴结活检可使早期乳腺癌患者免于腋窝淋巴结清扫及其带来的并发症,已成为早期乳腺癌患者的标准手术方式之一。但是精准医疗时代下,乳腺癌前哨淋巴结活检在临床实施过程中仍存在定位不够准确、淋巴结过度切除等问题。针对这些问题,本研究团队建立了精准前哨淋巴结活检的齐鲁流程、提出了前哨淋巴结区域精细解剖理念,并报道了前哨淋巴结的解剖变异以及与上肢引流淋巴结的位置关系。研究成果对于早期乳腺癌患者腋窝淋巴引流的理解和腋窝淋巴结的手术具有重要意义。

关键词: 乳腺癌, 前哨淋巴结, 淋巴引流, 朗格腋弓

Abstract: Sentinel lymph node biopsy of breast cancer, which can avoid axillary lymph node dissection and its complications, has become one of the standard surgical methods for patients with early breast cancer. However, in the era of precision medicine, the clinical implementation of sentinel lymph node biopsy has problems such as inaccurate localization and excessive lymph node resection. In response, our research team has established the Qilu Procedure for precise sentinel lymph node biopsy, proposed the concept of fine anatomy of the sentinel lymph node region, and reported the anatomical variation of sentinel lymph nodes and the positional relationship with the upper extremity draining lymph nodes. The results of this study have important implications for the understanding of axillary lymphatic drainage and operation of axillary lymph nodes in patients with early breast cancer.

Key words: Breast cancer, Sentinel lymph node, Lymphatic drainage, Langers axillary arch

中图分类号:

R737.9

杨其峰,张宁. 精准医疗时代的乳腺癌前哨淋巴结活检[J]. 山东大学学报 (医学版), 2022, 60(8): 1-5.

YANG Qifeng, ZHANG Ning. Sentinel lymph node biopsy of breast cancer in the era of precision medicine[J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5.

参考文献

[1] Giammarile F, Vidal-Si S, Paez D, et al. Sentinel Lymph Node Methods in Breast Cancer [J]. Semin Nucl Med, 2022, S0001-2998(22)00006-X. doi: 10.1053/j.semnuclmed.2022.01.006.
[2] Noguchi M, Inokuchi M, Noguchi M, et al. Axillary surgery for breast cancer: past, present, and future [J]. Breast Cancer, 2021, 28(1): 9-15.
[3] Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011(Alliance)randomized clinical trial [J]. JAMA, 2017, 318(10): 918-926.
[4] Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial [J]. Lancet Oncol, 2007, 8(10): 881-888.
[5] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021, 31(10): 87.
[6] Wise J. Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes [J]. BMJ, 2022, 377: o1226. doi: 10.1136/bmj.o1226.
[7] Vidya R, Khosla M, Laws S, et al. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: the UK SentiMag trial(SMART study)[J]. Surgeon, 2022, S1479-666X(22)00063-4. doi: 10.1016/j.surge.2022.04.006.
[8] Micha A, Parvaiz MA, ORiordan L, et al. Isotope-only localization for sentinel lymph node biopsy-medium-term oncological outcomes [J]. Clin Breast Cancer, 2022, 22(5):e636-e640.
[9] Zhu Y, Fan X, Yang D, et al. Contrast-enhanced ultrasound for precise sentinel lymph node biopsy in women with early breast cancer:a preliminary study [J]. Diagnostics(Basel), 2021, 11(11):2104. doi: 10.3390/diagnostics11112104.
[10] Shimazu K, Miyake T, Tanei T, et al. Real-time visualization of lymphatic flow to sentinel lymph nodes by contrast-enhanced ultrasonography with sonazoid in patients with breast cancer [J]. Ultrasound Med Biol, 2019, 45(10): 2634-2640.
[11] Li J, Li H, Guan L, et al. The value of preoperative sentinel lymph node contrast-enhanced ultrasound for breast cancer: a large, multicenter trial [J]. BMC Cancer, 2022, 22(1): 455. doi: 10.1186/s12885-022-09551-y.
[12] Zeng HC, Hu JL, Bai JW, et al. Detection of sentinel lymph nodes with near-infrared imaging in malignancies [J]. Mol Imaging Biol, 2019, 21(2): 219-227.
[13] Wang Z, Yang X, Wang J, et al. Real-time in situ navigation system with indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer [J]. Front Oncol, 2021, 11: 621914. doi: 10.3389/fonc.2021.621914. eCollection 2021.
[14] Li C, Liu P, Shao P, et al. Handheld projective imaging device for near-infrared fluorescence imaging and intraoperative guidance of sentinel lymph node resection [J]. J Biomed Opt, 2019, 24(8): 1-4.
[15] Wen S, Liang Y, Kong X, et al. Application of preoperative computed tomographic lymphography for precise sentinel lymph node biopsy in breast cancer patients [J]. BMC Surg, 2021, 21(1): 187. doi: 10.1186/s12893-021-01190-7.
[16] Li X, Chen S, Jiang L, et al. Precise intraoperative sentinel lymph node biopsies guided by lymphatic drainage in breast cancer [J]. Oncotarget, 2017, 8(38): 63064-63072.
[17] Xu L, Yang J, Du Z, et al. Redefining criteria to ensure adequate sentinel lymph node biopsy with dual tracer for breast cancer [J]. Front Oncol, 2020, 10: 588067. doi: 10.3389/fonc.2020.588067. eCollection 2020.
[18] Larson KE, Valente SA, Tu C, et al. Surgeon-associated variation in breast cancer staging with sentinel node biopsy [J]. Surgery, 2018, 164(4): 680-686.
[19] Olaya W, Wong J, Wong J, et al. When is a lymph node dissection a lymph node dissection? the number of lymph nodes resected in sentinel and axillary lymph node dissections [J]. Ann Surg Oncol, 2013, 20(2): 627-632.
[20] Dutta R, Kluftinger A, Macleod M, et al. Revisiting the “10% rule” in breast cancer sentinel lymph node biopsy: an approach to minimize the number of sentinel lymph nodes removed [J]. Am J Surg, 2012, 203(5): 623-627.
[21] Li X, Chen S, Duan Y, et al. Identification and preservation of stained non-sentinel lymph nodes in breast cancer [J]. Oncol Lett, 2020, 20(6): 373. doi: 10.3892/ol.2020.12236. Epub 2020 Oct 21.
[22] Li X, Kong X, Chen S, et al. Enlarged para-sentinel lymph node dissection is not necessary in breast cancer patients undergoing sentinel lymph node biopsy [J]. Breast J, 2019, 25(5): 1025-1028.
[23] Disipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis [J]. Lancet Oncol, 2013, 14(6): 500-515.
[24] Mclaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment [J]. J Clin Oncol, 2020, 38(20): 2341-2350.
[25] Ma X, Wen S, Liu B, et al. Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer [J]. J Oncol, 2019, 2019: 8637895. doi: 10.1155/2019/8637895.?eCollection 2019.
[26] Shao X, Sun B, Shen Y. Axillary reverse mapping(ARM): where to go [J]. Breast Cancer, 2019, 26(1): 1-10.
[27] Daniels IR, della Rovere GQ. The axillary arch of Langer - the most common muscular variation in the axilla [J]. Breast Cancer Res Treat, 2000, 59(1): 77-80.
[28] Baskin AS, Wang K, Maker AV. Langers arch: an anatomic variant complicating axillary node dissection [J]. Surgery, 2022, S0039-6060(22)00080-0. doi: 10.1016/j.surg.2022.02.001.
[29] Sang Y, Kong X, Li X, et al. Langers axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study [J]. Surg Oncol, 2019, 29: 48-52. doi: 10.1016/j.suronc.2019.03.003. Epub 2019 Mar 2.
[30] Borm KJ, Ernst L, Voppichler J, et al. Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer [J]. Radiat Oncol, 2022, 17(1): 27. doi: 10.1186/s13014-021-01964-6.

相关文章 15

[1]	古春青,郭睿思,周勤勤,刘恒辉,巴婉玉,孙士玲,王冰,郑玉玲,吴宿慧. 基于网络药理学和动物实验探讨酸枣仁-远志药对治疗乳腺癌相关性失眠的作用机制[J]. 山东大学学报 (医学版), 2026, 64(1): 99-108.
[2]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[3]	王雪梅,杨豪,宋洋,程世超,张婷婷,王艳春. 抗糖尿病药物与女性恶性肿瘤的因果关联:一项两样本孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(6): 67-77.
[4]	余之刚,郑超. 乳腺癌多学科诊疗的现状、挑战与创新模式[J]. 山东大学学报 (医学版), 2025, 63(1): 1-9.
[5]	山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16.
[6]	程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24.
[7]	王敏, 李习平, 檀军, 邱梅, 侯泽宇, 田莹, 罗鸿莹, 范超文, 齐玲, 俞琦, 谢薇. 慢病毒载体介导Gag-Caspase-8诱导三阴性乳腺癌原代细胞凋亡及S期阻滞[J]. 山东大学学报 (医学版), 2025, 63(1): 25-34.
[8]	张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42.
[9]	宋雅雯,郭联涛,孔德光,孙圣荣. VTCN1导致HR+乳腺癌预后不良及内分泌治疗耐药[J]. 山东大学学报 (医学版), 2025, 63(1): 43-59.
[10]	刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72.
[11]	孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80.
[12]	李永,崔书君,杨飞,张凡,殷晓霞. 基于增强MRI的亚区域影像组学模型可预测乳腺癌患者新辅助化疗后的病理完全反应[J]. 山东大学学报 (医学版), 2025, 63(1): 81-89.
[13]	袁宗怀,潘广晔,迟曰梅,安传国,张永刚. 孟德尔随机化分析低级别浆液性卵巢癌与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2025, 63(1): 99-107.
[14]	艾宪程,王斐,周文重,于理想,周飞,相玉娟,李亮,余之刚. 山东省38所三甲医院乳腺多学科诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(1): 108-114.
[15]	刘向荣,张新胜,杨荩冉,杨雪艳,刘钊,刘英华. ω-6/ω-3多不饱和脂肪酸比值对不同肿瘤发病风险的系统综述和Meta分析[J]. 山东大学学报 (医学版), 2024, 62(8): 34-48.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed